CLINICAL STAGE IVA GASTRIC CANCER AJCC V8

This study is comparing two treatment approaches for patients with a specific type of stomach or gastroesophageal junction cancer that has not spread widely. The goal is to see if using an immunotherapy drug (atezolizumab) combined with chemotherapy before and after surgery works…

This study is for people with advanced stomach or esophageal cancer that has spread to only a few other places in the body. It tests if adding a short course of targeted radiation to standard chemotherapy works better than chemotherapy alone to control the cancer and help patient…

This study is testing a new treatment approach for patients with stomach or gastroesophageal cancer that can be surgically removed. It combines two immunotherapy drugs (nivolumab and ipilimumab) with chemotherapy and radiation before surgery, aiming to shrink the tumor and help t…

This early-stage study is testing whether delivering a chemotherapy drug called paclitaxel directly into the abdominal cavity is safe and tolerable for people with advanced stomach or gastroesophageal cancer that has spread to the lining of the abdomen. The main goal is to find t…

This early-stage trial is testing whether a shorter, 2-week course of combined chemotherapy and radiation before surgery is safe and effective for patients with operable stomach cancer. The study involves 25 participants and compares this shorter approach to the standard 5-week t…